Inventor · disambiguated record
Eugene D. Kwon
Also filed as: KWON EUGENE · KWON EUGENE D · KWON IV EUGENE D
14 granted patents·22 pending applications·145 citations·filing 2005–2024
91Inventor score
Files withMAYO FOUNDATION17MAYO FOUND MEDICAL EDUCATION & RES10KWON EUGENE D4NAM DANIEL S2AMAZON TECH INC1
Top patents by PatentIndex Score
36 records- 0198US7892540B2B7-H1 and methods of diagnosis, prognosis, and treatment of cancerMAYO FOUNDATION·Filed 2005·Granted Feb 22, 2011·84 cites·22 claims
- 0295US8747833B2B7-H1 and methods of diagnosis, prognosis, and treatment of cancerCHEN LIEPING·Filed 2011·Granted Jun 10, 2014·23 cites·3 claims
- 0393US9803015B2Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUNDATION·Filed 2016·Granted Oct 31, 2017·8 cites·7 claims
- 0491US9302005B2Methods and materials for treating cancerMAYO FOUNDATION·Filed 2014·Granted Apr 5, 2016·11 cites·7 claims
- 0591US2024352120A1Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUND MEDICAL EDUCATION & RES·Filed 2024·Application pending·0 cites
- 0683US11026881B2Sedative laced toothpasteNAM DANIEL S·Filed 2019·Granted Jun 8, 2021·2 cites·1 claims
- 0782US10860303B2Selective operating system patching/updatingNINTENDO CO LTD·Filed 2013·Granted Dec 8, 2020·9 cites·18 claims
- 0881US11939378B2Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUND MEDICAL EDUCATION & RES·Filed 2021·Granted Mar 26, 2024·0 cites·3 claims
- 0979US11782978B1Techniques for storing and analyzing dataAMAZON TECH INC·Filed 2019·Granted Oct 10, 2023·3 cites·20 claims
- 1079US11242387B2Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Granted Feb 8, 2022·0 cites·1 claims
- 1173US9121853B2B7-H4 expression on tumor vasculatureKWON EUGENE D·Filed 2007·Granted Sep 1, 2015·5 cites·11 claims
- 1268US2018179281A1Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUND MEDICAL EDUCATION & RES·Filed 2018·Application pending·0 cites
- 1367US2018100015A1Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUND MEDICAL EDUCATION & RES·Filed 2017·Application pending·0 cites
- 1467US2015044165A1Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUNDATION·Filed 2014·Application pending·0 cites
- 1566US11136393B2Methods for treating cancer in patients with elevated levels of BimMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Granted Oct 5, 2021·0 cites·5 claims
- 1664US11986551B2Sedative laced toothpasteNAM DANIEL S·Filed 2021·Granted May 21, 2024·0 cites·1 claims
- 1763US2016257953A1Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUNDATION·Filed 2016·Application pending·0 cites
- 1862US2010203035A1B7-h3 in cancerKWON EUGENE D·Filed 2008·Application pending·0 cites
- 1962US2020326344A1Soluble B7-H1MAYO FOUND MEDICAL EDUCATION & RES·Filed 2020·Application pending·0 cites
- 2061US2016264667A1Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic targetMAYO FOUNDATION·Filed 2015·Application pending·0 cites
- 2159US10259875B2Methods for treating cancer in patients with elevated levels of BIMMAYO FOUND MEDICAL EDUCATION & RES·Filed 2014·Granted Apr 16, 2019·0 cites·10 claims
- 2259US2014335541A1B7-h1 and b7-h4 in cancerMAYO FOUNDATION·Filed 2014·Application pending·0 cites
- 2358US2014329248A1B7-h1 and survivin in cancerMAYO FOUNDATION·Filed 2014·Application pending·0 cites
- 2458US2017363634A1Soluble B7-H1MAYO FOUND MEDICAL EDUCATION & RES·Filed 2017·Application pending·0 cites
- 2557US2015111232A1Soluble B7-H1MAYO FOUNDATION·Filed 2014·Application pending·0 cites
- 2656US2016153996A1B7-h1 and b7-h4 in cancerMAYO FOUNDATION·Filed 2016·Application pending·0 cites
- 2756US2017146539A1B7-h3 in cancerMAYO FOUNDATION·Filed 2017·Application pending·0 cites
- 2855US10167336B2Methods and materials for treating cancerMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted Jan 1, 2019·0 cites·12 claims
- 2955US2016154000A1B7-h1 and survivin in cancerMAYO FOUNDATION·Filed 2016·Application pending·0 cites
- 3054US2009215084A1B7-h1 and b7-h4 in cancerMAYO FOUNDATION·Filed 2007·Application pending·0 cites
- 3153US2013122021A1B7-h3 in cancerMAYO FOUNDATION·Filed 2013·Application pending·0 cites
- 3252US2016051675A1B7-h4 expression on tumor vasculatureMAYO FOUNDATION·Filed 2015·Application pending·0 cites
- 3352US2009176317A1Soluble B7-H1MAYO FOUNDATION·Filed 2008·Application pending·0 cites
- 3448US2010015642A1B7-h1 and survivin in cancerKWON EUGENE D·Filed 2007·Application pending·0 cites
- 3547US2011020325A1Methods for reducing granulomatous inflammationKWON EUGENE D·Filed 2009·Application pending·0 cites
- 3643US2013251736A1Methods for reducing granulomatous inflammationMAYO FOUNDATION·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →